Justia Products Liability Opinion Summaries

Plaintiff filed suit against Novartis alleging that Novartis negligently failed to provide adequate warnings for two drugs she took, Aredia and Zometa, after having two of her teeth extracted. Plaintiff developed osteonecrosis of the jaw (ONJ) after the extraction. Plaintiff was awarded $225,000 in compensatory damages and Novartis appealed. The court concluded that a jury could reasonably find that plaintiff's injury was the natural and probable consequence of Novartis's behavior and rejected Novartis's arguement that plaintiff did not establish that her injuries were proximately caused by inadequate warnings; the district court did not err in applying Missouri law where Missouri had the most significant relationship to the punitive damages claim; and Novartis correctly reasoned that the MedWatch checkmarks were inadmissible hearsay, out-of-court assertions offered for their truth but Novartis failed to demonstrate the prejudice required for a new trial. The court concluded, however, that the district court abused its discretion in awarding plaintiff full costs for depositions conducted as part of multi-district litigation. Accordingly, the court affirmed in Case No. 12-3121 and vacated in Case No. 12-3409. View "Winter v. Novartis Pharmaceuticals Corp." on Justia Law

OMJP appealed from the district court's denial of its motion for relief from judgment under Federal Rule of Civil Procedure 60(b)(2) and (3). In Levaquin I, the court upheld a jury award in compensatory damages against OMJP for Achilles tendon injuries plaintiff suffered while taking OMJP's prescription antibiotic Levaquin. In this appeal, OMJP contended that the district court abused its discretion in denying OMJP relief under Rule (60)(b)(2) based on the delinquent and belated disclosure of an expert's calculation regarding the relative risk of Achilles tendon rupture to certain patients. The court concluded that the district court did not abuse its discretion in denying relief based on OMJP's claim of "newly discovered evidence" where the evidence was merely cumulative or impeaching and OMJP had not demonstrated that it was probable it would produce a different result. In regards to OMJP's misconduct claim under Rule 60(b)(3), the court concluded that the district court did not abuse its discretion in finding that the lack of the expert's calculation did not prevent OMJP from mounting a vigorous defense and that any misconduct did not warrant a new trial. Accordingly, the court affirmed the judgment of the district court. View "Schedin v. Ortho-McNeil-Janssen Pharmaceuticals" on Justia Law

Cavalier Manufacturing, Inc. appealed a circuit court order that denied its motion to alter, amend, or vacate an arbitration award entered in favor of Janie Gant. Gant purchased a mobile home manufactured by Cavalier from Demopolis Home Center, L.L.C. ("DHC"). At the time of purchase, Gant and representatives of Cavalier and DHC executed an alternative-dispute-resolution agreement in which they agreed to arbitrate any disputes that might arise among them stemming from Gant's purchase of the mobile home. The mobile home was also covered by a manufacturer's warranty issued by Cavalier that likewise contained a provision requiring arbitration of any disputes that might arise between her and Cavalier relating to the mobile home. Gant was not satisfied with the manner in which DHC delivered and installed the mobile home on her property. Eventually Gant sued, and the matter was submitted to arbitration. The arbitrator awarded Gant $45,550 on her breach-of-express-warranty claim, plus an additional sum to be determined for attorney fees. Cavalier argued on appeal that the trial court erred by confirming the arbitration award in favor of Gant. Finding no error, the Supreme Court affirmed. View "Cavalier Manufacturing, Inc. v. Gant " on Justia Law

The plaintiffs allege that they ingested metoclopramide, the generic equivalent of the prescription drug Reglan, and, as a result, developed a serious neurological disorder, tardive dyskinesia. The labeling for the drugs recommends short-term use for heartburn and acute and recurrent bloating: up to 12 weeks in adults for heartburn. Reglan and metoclopramide have not been shown to be either efficacious or safe for long-term treatment; the drugs affect the brain’s movement center, typically causing involuntary, repetitive movements. Overuse can result in symptoms including tardive dyskinesia, dystonia, and akathisia, Parkinsonism, and Reglan-induced tremors. Reglan and metoclopramide have also been associated with central nervous system disorders, depression with suicidal ideation, visual disturbances, and other problems. The plaintiffs sued both the generic and brand-name manufacturers, alleging various product-liability claims. The district court dismissed, finding the metoclopramide claims preempted by the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 301-399f, and that the brand-name manufacturers are not liable because none of the plaintiffs ingested Reglan. The Sixth Circuit affirmed and denied the plaintiffs’ motion to certify a proposed question to the Tennessee Supreme Court. View "Speed v. Wyeth Pharm., Inc." on Justia Law

Plaintiff filed a products liability action against TI after her son died from cardiac arrest when he was struck by a taser. A jury found in favor of plaintiff, awarding her $10 million in compensatory damages, which the district court remitted to about $6.15 million before deducting certain offset amounts received by plaintiff, resulting in a final award of about $5.5 million. TI appealed. The court held that the district court did not err in entering judgment in favor of plaintiff on the liability aspect of the negligence claim in accordance with the jury's verdict. However, the damages award was not supported by the evidence and the court remanded on that issue. Therefore, the court affirmed the district court's judgment in part, vacated in part, and remanded for further proceedings. View "Fontenot v. Taser Int'l, Inc." on Justia Law

Plaintiffs, Nelson and Elaine Cruz, filed a complaint against the car dealership where Nelson purchased his vehicle (Ricky Smith), alleging that while Nelson was cleaning the inside of his minivan, both front airbags unexpectedly deployed, injuring him. Plaintiffs' complaint alleged negligence, strict products liability, negligent misrepresentation, and res ipsa loquitur. In addition, Elaine sought damages for loss of consortium. The trial justice granted Ricky Smith's motion for summary judgment on all counts. The Supreme Court affirmed, holding that the hearing justice properly granted summary judgment in Ricky Smith's favor on Nelson's claims of negligence and misrepresentation, and consequently, Elaine was barred from recovering damages for loss of consortium. View "Cruz v. DaimlerChrysler Motors Corp." on Justia Law

Appellant's decedents were passengers in a 1979 Beechcraft Baron airplane when, in 2008, the left engine lost power and the plane crashed, killing all persons on board. Appellant filed suit on behalf of his decedents' estates, claiming wrongful death based on negligence and products liability. Appellant named as defendants the manufacturers of the airplane (Appellees), among others. Appellees moved for summary judgment on the grounds that Appellant's suit was barred by the eighteen-year statute of repose set forth in the General Aviation Revitalization Act (GARA). The circuit court granted summary judgment to Appellees, finding that Appellant's claims were barred by GARA and that neither the fraud exception nor the new-part rolling provision of GARA applied. The Supreme Court affirmed, holding that the circuit court did not err in granting summary judgment to Appellees where (1) a genuine issue of material fact did not exist with respect to whether the fraud exception to GARA applied here; and (2) Appellant's allegations that the publication of an allegedly defective flight manual were insufficient to invoke GARA's new-part rolling provision as a matter of law. View "Tillman v. Raytheon Co." on Justia Law

This case arose when groups of plaintiffs filed product liability actions against four manufacturers of transvaginal mesh devices, including Boston Scientific. Three groups filed similar motions proposing that the state court assign each group to a single Judge for purposes of discovery and trial. Two district judges granted plaintiffs' motions and remanded to state court on the ground that no case included more than 100 plaintiffs and plaintiffs had not proposed to the state court that the actions be tried jointly. The court granted Boston Scientific leave to appeal and vacated the order remanding to state court where the three groups of plaintiffs have already proposed to try their cases jointly within the meaning of the Class Action Fairness Act of 2005 (CAFA), 28 U.S.C. 1332(d)(11)(B)(i), because plaintiffs' counsel urged the state court to assign the claims of more than 100 plaintiffs to a single judge. View "Atwell, et al. v. Boston Scientific Corp." on Justia Law

A concrete truck collided with a shuttle bus used to transport passengers between an airport and a rental car facility. A passenger who was injured during the collision and his wife filed an action against the bus owner, bus manufacturer, manufacturer of the bus windows, and franchisor of the rental car business. Plaintiffs based their claims in negligence and products liability, arguing that the bus was unsafe because it did not have passenger seatbelts, had windows made of tempered glass, and provided perimeter seating instead of forward-facing rows. A jury found Plaintiffs had sustained damages but assessed 100 percent of the fault to the corporate owner of the concrete truck, which had previously settled with Plaintiffs. On appeal, the court of appeals held that federal law preempted the seatbelt and window-glass claims and ruled that the trial court erred by failing to grant a directed verdict on the perimeter-seating claim. The Supreme Court remanded. On remand, the court of appeals affirmed its prior judgment. The Supreme Court reversed, holding (1) the seatbelt and window-glass claims were not preempted by federal law; and (2) the evidence sufficiently demonstrated causation in fact as to the perimeter-seating claim. Remanded.View "Lake v. The Memphis Landsmen, LLC" on Justia Law

Bruce Martin filed suit against CTB for negligent misrepresentation and breach of express warranty after the power sweeps it purchased from CTB did not work. The court concluded that it's decision in Dannix Painting, LLC v. Sherwin-Williams foreclosed Bruce Martin's argument that the district court erred in concluding that Missouri's economic loss doctrine precluded its negligent misrepresentation claim. Further, the court concluded that the district court did not err in granting summary judgment to CTB on Bruce Martin's breach of express warranty claim. Under Indiana law, the court agreed with the district court that Bruce Martin had alleged a defect in the design of the sweeps that was not covered by CTB's warranty against "defects in material and workmanship." Accordingly, the court affirmed the judgment of the district court. View "Bruce Martin Construction, Inc. v. CTB, Inc." on Justia Law